Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

PLX PHARMA INC COM (DPRX)

1.338 +0.038 (+2.923%)

4/19/2017  3:59pm

Open:

N/A

Pre. Close:

1.300

High:

N/A

Low:

N/A

Volume:

0

Market Cap:

N/A

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.94 - 5.98

5.98 - 6.07

Low:

5.38 - 5.41

5.41 - 5.46

Close:

5.63 - 5.7

5.7 - 5.86

Technical analysis  (as of: 2017-06-26 11:32:30 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 10.29     One year: 12.61

Support:

Support1: 5.60    Support2: 4.66

Resistance:

Resistance1: 8.81    Resistance2: 10.80

Pivot:

6.45

Moving Averages:

MA(5): 5.87     MA(20): 6.82

MA(100): 10.09     MA(250): 47.47

MACD:

MACD(12,26): -0.97     Signal(12,26,9): -0.96

%K %D:

%K(14,3): 4.55     %D(3): 5.96

RSI:

RSI(14): 23.42

52-Week:

High: 17.751  Low: 1.050  Change(%): -93.8

Average Vol(K):

3-Month: 11  10-Days 7

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
DPRX has closed above bottom band by 24.4%. Bollinger Bands are 10% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 12 Jun 2017 10:41:15 GMT
PLx Pharma Inc. Announces Pricing of Registered Direct Offering

Mon, 01 May 2017 11:02:42 GMT
PLx Pharma Appoints Michael J. Dillon as Vice President, Sales and Marketing

Thu, 22 Dec 2016 22:56:47 GMT
Dipexium shares surge on announced merger with PLx Pharma

Tue, 14 Feb 2017 12:30:36 GMT
PLx Pharma Announces Publication of Positive Antiplatelet Data for Aspertec in ...

Thu, 22 Dec 2016 21:56:15 GMT
BRIEF-Dipexium and PLX Pharma announce merger agreement

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

11.23

Shares Float (M)

7.13

% Held by Insiders

39.34

% Held by Institutions

29.00

Shares Short (K)

304

Shares Short Prior Month (K)

267

Stock Financials

EPS

-2.057

EPS Est. Current Year

-1.570

EPS Est. Next Year

-0.540

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

1.350

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-54.0

Return on Equity (ttm)

-93.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-15.58

Levered Free Cash Flow (M)

-8.67

FoxReading.com

Valuation

P/E

-2.80

P/E Growth Ratio

P/BV

4.26

P/S

P/CF

-4.14

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.